concept

RA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about RA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

158Connections
30Hypotheses
30Analyses
0Outgoing
50Incoming

Summary

RA is a concept in neurodegeneration research. Key relationships include: implicated in, associated with. Connected to 158 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info
NameRA
SummaryPage for RA Capital Management
Key Genes/ProteinsRBP, MAP1B, MAP2, MAP6, GLUT4, PPAR
Linked Hypotheses291 hypotheses

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

RA Capital Management

institution · 1417 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Clinical Management Guide for CBS/PSP

therapeutic · 15224 words

Novel Therapy Index

idea · 10647 words

CBS/PSP Supplements Guide

therapeutic · 6929 words

Device Therapies Comparison for CBS/PSP

therapeutic · 6867 words

Pathway Diagram

graph TD
    RA["RA"]
    MAP1B["MAP1B"] -->|"implicated in"| RA
    MAP2["MAP2"] -->|"implicated in"| RA
    MAP6["MAP6"] -->|"implicated in"| RA
    GLUT4["GLUT4"] -->|"implicated in"| RA
    PPAR["PPAR"] -->|"implicated in"| RA
    RAB7A["RAB7A"] -->|"implicated in"| RA
    LRP2["LRP2"] -->|"implicated in"| RA
    ACTB["ACTB"] -->|"implicated in"| RA
    CTSD["CTSD"] -->|"implicated in"| RA
    ATG["ATG"] -->|"implicated in"| RA

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (158)

SourceRelationTypeStr
RBPassociated_withprotein0.56
MAP1Bimplicated_ingene0.50
MAP2implicated_ingene0.50
MAP6implicated_ingene0.50
GLUT4implicated_ingene0.50

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
APOE4-Specific Lipidation Enhancement Therapy 0.845 Alzheimer's disease -
Closed-loop transcranial focused ultrasound to restore hippo 0.709 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II SST interneurons to block t 0.697 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop focused ultrasound targeting EC-II SST interneur 0.697 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2-Dependent Microglial Senescence Transition 0.692 neurodegeneration Gene expression changes in aging mouse b
Closed-loop transcranial focused ultrasound with 40Hz gamma 0.689 Alzheimer's disease Circuit-level neural dynamics in neurode
Gamma entrainment therapy to restore hippocampal-cortical sy 0.681 Alzheimer's disease Circuit-level neural dynamics in neurode
CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Wind 0.674 neuroimmunology What is the temporal sequence of TREM2 s
Closed-loop tACS targeting EC-II PV interneurons to suppress 0.670 Alzheimer's disease Circuit-level neural dynamics in neurode
Beta-frequency entrainment therapy targeting PV interneuron- 0.669 Alzheimer's disease Circuit-level neural dynamics in neurode
Transcriptional Autophagy-Lysosome Coupling 0.665 neurodegeneration Autophagy-lysosome pathway convergence a
Stathmin-2 Splice Switching to Prevent Axonal Degeneration A 0.664 neurodegeneration RNA binding protein dysregulation across
STMN2 Restoration as a Prerequisite for Axon Growth After TD 0.658 neurodegeneration What molecular mechanisms enable functio
Temporal SPP1 Inhibition During Critical Windows 0.650 neuroinflammation What molecular mechanisms mediate SPP1-i
Selective Acid Sphingomyelinase Modulation Therapy 0.648 neurodegeneration Lipid raft composition changes in synapt
Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone 0.645 neurodegeneration What are the precise temporal dynamics o
Closed-loop transcranial alternating current stimulation to 0.639 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen 0.639 neurodegeneration Gene expression changes in aging mouse b
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P 0.638 neurodegeneration Senolytic therapy for age-related neurod
TREM2-Dependent Microglial Phagocytosis Acts as a Strain Sel 0.636 neurodegeneration What are the specific molecular determin
Closed-loop transcranial focused ultrasound to restore hippo 0.633 Alzheimer's disease Circuit-level neural dynamics in neurode
Closed-loop transcranial focused ultrasound targeting EC-II 0.633 Alzheimer's disease Circuit-level neural dynamics in neurode
IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microgl 0.632 neuroinflammation How do oligodendrocytes initiate neuroin
CYP46A1 Overexpression Gene Therapy 0.631 neurodegeneration Lipid raft composition changes in synapt
Closed-loop tACS targeting entorhinal cortex layer II SST in 0.625 Alzheimer's disease Circuit-level neural dynamics in neurode
Circadian Glymphatic Entrainment via Targeted Orexin Recepto 0.623 neurodegeneration Perivascular spaces and glymphatic clear
CSF Biomarker-Guided ABCA7 Therapeutic Dosing 0.619 neurodegeneration Why does the V1613M variant reduce amylo
Chromatin Remodeling-Mediated Nutrient Sensing Restoration 0.619 neurodegeneration Epigenetic reprogramming in aging neuron
Integrated Biomarker Panel for Therapeutic Window Identifica 0.615 neurodegeneration What are the precise temporal dynamics o
APOE-Dependent Autophagy Restoration 0.615 neurodegeneration Mechanistic role of APOE in neurodegener

Mentioning Analyses (30)

Scientific analyses that reference this entity

How do sphingomyelin/ceramide ratios specifically regulate BACE1 clustering and

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.596

What are the specific molecular determinants that govern tau strain selection du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.636

What are the cell-type-specific transcriptomic signatures of vulnerability in SE

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.576

How do synthetic EVs achieve brain-specific targeting while avoiding reticuloend

drug delivery | 2026-04-15 | 0 hypotheses

Are age-related static epigenetic patterns pathogenic or protective compensatory

epigenetics | 2026-04-15 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614] Han QQ, Shen SY, Liang LF, Chen XR, Yu J Brain Behav Immun 2024 1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] Zhang T, Xu D, Trefts E, Lv M, Inuzuka H Science 2023 1
Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia J Inflamm Res 2022 1
TREM2, microglia, and Alzheimer's disease. [PMID:33516818] Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Mech Ageing Dev 2021 1
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] Zhou Y, Song WM, Andhey PS, Swain A, Lev Nat Med 2020 1
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease. [PMID:28802038] Ulland TK, Song WM, Huang SC, Ulrich JD, Cell 2017 1
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] Krasemann S, Madore C, Cialic R, Baufeld Immunity 2017 1
Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and T [PMID:41833042] ["Lyu G", "Li D"] CNS & neurological disorders d 2026 0
Emerging pathological mechanisms of Alzheimer's disease pathogenesis: from neuro [PMID:41858793] ["Wang R", "Feng Y", "Zhou Z", "Jiang J" Frontiers in aging neuroscienc 2026 0
Human CSF proteogenomics links genetic variation to neurodegenerative disease pr [PMID:41757182] ["Puerta R", "Garc\u00eda-Gonz\u00e1lez medRxiv : the preprint server 2026 0
PLCG2 signaling and genetic resilience in Alzheimer's disease. [PMID:41888907] Tsai AP, Martin AK, Mi A, Yeh AE, Ramire Molecular neurodegeneration 2026 0
TREM2 deficiency delays postnatal microglial maturation and synaptic pruning, le [PMID:41930604] Yang HC, Deng YS, Zhang J, Zhang T, Song J Alzheimers Dis 2026 0
A scalable human-zebrafish xenotransplantation model reveals gastrosome-mediated [PMID:41957412] Villani A, Wittmann J, Wyss T, Mallona I Commun Biol 2026 0
Dual Role of Microglial TREM2 in Neuronal Degeneration and Regeneration After Ax [PMID:41963086] Pottorf TS, Lane EL, Haley-Johnson Z, Uk J Neurosci 2026 0
TREM2-mediated microglial phagocytosis of inhibitory synapses contributes to pro [PMID:41965330] Wang X, Zhou H, Zhai Y, Zhang Y, Cheng Y Cell Death Discov 2026 0
Investigating the Potential of Gene Editing Technologies in Enhancing Stem Cell [PMID:41926312] ["Mehrabadi S"] Current aging science 2026 0
TREM2 in neurodegeneration and diseases. [PMID:41792456] ["Abdulkhaliq A", "Alasiri G", "Kim B", Molecular psychiatry 2026 0
Berbamine hydrochloride as a brain penetrant galectin 3 inhibitor in a model of [PMID:41772384] ["Siew J", "Lee C", "Chen H", "Lin H", " Brain : a journal of neurology 2026 0
The microglial TREM2 receptor programs hippocampal development in a mouse model [PMID:41887542] Ahmed S, Bowers C, Munoz-Martin J, Jamwa Brain, behavior, and immunity 2026 0
Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842] Alhusaini M, Mussa BM, Ilce BY, Alhaj H, Frontiers in aging neuroscienc 2026 0